Life Science REIT (LABS)

Sector:

Real Estate

Index:

FTSE Small Cap

38.30p
   
  • Change Today:
    -1.40p
  • 52 Week High: 66.00p
  • 52 Week Low: 31.50p
  • Currency: UK Pounds
  • Shares Issued: 350.00m
  • Volume: 595,019
  • Market Cap: £134.05m
  • Beta: 0.32

Life Science REIT pleased with performance since IPO

By Josh White

Date: Monday 23 May 2022

LONDON (ShareCast) - (Sharecast News) - Life Science REIT reported a portfolio value of £192.2m at the end of 2021 in its results on Monday, including a revaluation gain of £14.5m.
The AIM-traded investor in life science properties said its net asset value was £350.6m, or 100.2p per share, on 31 December.

Its revenue for the period from formation on 1 August to the end of the year totalled £0.5m, and its operating loss before gains on investment properties was £0.3m.

The real estate investment trust recorded an IFRS profit before tax of £7.7m.

Its IFRS earnings per share were 2.2p, while EPRA losses per share came in at 0.1p.

Since the end of 2021, all of Life Science's initial public offering proceeds had been deployed following two further transactions.

In March, it entered into a debt financing facility of £150m with HSBC UK, consisting of a £75m three-year term loan facility and an equally sized revolving credit facility.

The first drawdown of £64m was made in May.

The company said it intended to declare its first dividend later in the year for the period from admission in November to 30 June, and after that to adopt a progressive dividend policy, with dividends paid semi-annually.

"In the six months following the company's IPO in November last year, we have successfully deployed the £350m raised at IPO in a highly attractive blend of seven exciting projects in the golden triangle of life science innovation in Oxford, Cambridge and London," said chair Claire Boyle.

"These projects are diversified by location, asset size and development stage and comprise immediately income producing assets through to new build and conversion opportunities.

"Life science property is a highly attractive asset class, and the potential to add value through active asset management means that we are confident of making further progress in the year ahead."

At 1100 BST, shares in Life Science REIT were flat at 100p.

Reporting by Josh White at Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

LABS Market Data

Currency UK Pounds
Share Price 38.30p
Change Today -1.40p
% Change -3.53 %
52 Week High 66.00p
52 Week Low 31.50p
Volume 595,019
Shares Issued 350.00m
Market Cap £134.05m
Beta 0.32

LABS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.52% below the market average8.52% below the market average8.52% below the market average8.52% below the market average8.52% below the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average
Price Trend
30.24% below the market average30.24% below the market average30.24% below the market average30.24% below the market average30.24% below the market average
44.83% below the sector average44.83% below the sector average44.83% below the sector average44.83% below the sector average44.83% below the sector average
Income
8.67% below the market average8.67% below the market average8.67% below the market average8.67% below the market average8.67% below the market average
39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average
Growth
74.60% above the market average74.60% above the market average74.60% above the market average74.60% above the market average74.60% above the market average
85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average

LABS Dividends

  Latest Previous
  Interim 2nd Interim
Ex-Div 03-Oct-24 04-Apr-24
Paid 31-Oct-24 13-May-24
Amount 1.00p 1.00p

Trades for 21-Nov-2024

Time Volume / Share Price
16:37 1,569 @ 38.30p
16:37 63,599 @ 38.30p
16:35 14,820 @ 38.30p
16:29 926 @ 38.70p
16:29 926 @ 38.70p

Top of Page